IOVA
NASDAQ · Biotechnology
Iovance Biotherapeutics Inc
$6.34
+0.13 (+2.09%)
Performance
1D
—
1W
+46.93%
1M
+49.88%
3M
+71.35%
6M
+30.99%
1Y
+30.99%
YTD
+30.99%
Open$6.57
Previous Close$6.21
Day High$6.92
Day Low$5.88
52W High$6.39
52W Low$1.76
Volume—
Avg Volume19.38M
Market Cap2.72B
P/E Ratio—
EPS$-0.95
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$4.30
Above
RSI (14)
55.3
Neutral
Analyst Ratings
Strong Buy
16 analysts
Price Target
+763.9% upside
Current
$6.34
$6.34
Target
$54.77
$54.77
$41.45
$54.77 avg
$77.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 317.51M | 337.04M | 333.93M |
| Net Income | -471,098,878 | 23.64M | 18.09M |
| Profit Margin | -148.4% | 7.0% | 5.4% |
| EBITDA | -442,723,578 | 42.24M | 40.52M |
| Free Cash Flow | — | 21.56M | 19.96M |
| Rev Growth | — | +17.4% | +6.9% |
| Debt/Equity | 0.00 | 0.20 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |